Literature DB >> 9773258

Autoantibodies to coagulation factors and bleeding disorders.

A E Ahmed1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9773258     DOI： 10.1007/BF02737641

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN： 1080-0549            Impact factor:   8.667


× No keyword cloud information.
  17 in total

Review 1.  Molecular and cellular biology of blood coagulation.

Authors:  B Furie; B C Furie
Journal:  N Engl J Med       Date:  1992-03-19       Impact factor: 91.245

Review 2.  Cofactor proteins in the assembly and expression of blood clotting enzyme complexes.

Authors:  K G Mann; R J Jenny; S Krishnaswamy
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

Review 3.  The molecular basis of blood coagulation.

Authors:  B Furie; B C Furie
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

4.  The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers.

Authors:  R J Wise; D D Pittman; R I Handin; R J Kaufman; S H Orkin
Journal:  Cell       Date:  1988-01-29       Impact factor: 41.582

Review 5.  Inhibitors in hemophilia patients: current status and management.

Authors:  L Aledort
Journal:  Am J Hematol       Date:  1994-11       Impact factor: 10.047

6.  The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups.

Authors:  R Prescott; H Nakai; E L Saenko; I Scharrer; I M Nilsson; J E Humphries; D Hurst; G Bray; D Scandella
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

7.  Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces.

Authors:  K Naito; K Fujikawa
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

8.  Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function.

Authors:  V D Chouhan; R A De La Cadena; C Nagaswami; J W Weisel; M Kajani; A K Rao
Journal:  Thromb Haemost       Date:  1997-02       Impact factor: 5.249

Review 9.  Acquired inhibitors.

Authors:  A J Cohen; C M Kessler
Journal:  Baillieres Clin Haematol       Date:  1996-06

10.  Study on an antibody against F1F2 fragment of human factor V in a patient with Hashimoto's disease and bullous pemphigoid.

Authors:  E Suehisa; M Toku; N Akita; R Fushimi; T Takano; H Tada; Y Iwatani; N Amino
Journal:  Thromb Res       Date:  1995-01-01       Impact factor: 3.944
View more
  2 in total

1.  Management of rare acquired bleeding disorders.

Authors:  Marzia Menegatti; Eugenia Biguzzi; Flora Peyvandi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  A case report of severe bleeding due to lupus anticoagulant hypoprothrombinemia syndrome.

Authors:  Elsa Meireles; Filipe Machado; Luís Teles; Anna Chumakova; Joana Sequeira; Ana Spínola
Journal:  J Thromb Thrombolysis       Date:  2020-02       Impact factor: 2.300
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.